MedVi vs Enhance MD: Semaglutide, Tirzepatide and Pricing Compared
MedVi vs Enhance MD is a comparison of two telehealth platforms that prescribe compounded GLP-1s. Quick verdict: if you prioritize the lowest entry price and choice of both semaglutide and tirzepatide, Enhance MD is the cheaper, multi-compound option; if you want a simple, no-clinic process and 24/7 certified medical support with a promotional semaglutide price, MedVi is the clearer fit.
Explore MedVi pricing and process
Head-to-head: pricing, compounds, and care model
Both platforms use clinician-directed telehealth and offer compounded medications that are not FDA-approved finished products. They differ most notably on starting price, compound availability, pricing model during titration, and support style. Below we compare these distinctive differences directly using only the supplied facts.
1. Starting price and promotional offers
MedVi advertises a winter promotional first-month price of $179 for semaglutide that includes fast, free shipping. Enhance MD advertises a lower first-month rate for semaglutide from $49 and tirzepatide from $99. Both providers present first-month introductory prices; Enhance MD’s semaglutide first month is the lowest first-month semaglutide price cited.
See Enhance MD first-month offers
2. Compound options: semaglutide only vs semaglutide plus tirzepatide
MedVi offers clinically dosed compounded semaglutide only. Enhance MD offers both semaglutide and tirzepatide, with stated first-month starting prices of $49 and $99 respectively. If access to tirzepatide on the same platform is important, Enhance MD supplies that option.
3. Pricing behavior and ongoing costs
MedVi notes a promotional-first-month price of $179 but states ongoing standalone months can be $299 and a three-month plan is available at $649. Enhance MD emphasizes flat-rate pricing that stays the same at every dose with no fee escalation during titration. The evidence shows MedVi’s ongoing monthly cost rises after the promo while Enhance MD promotes predictable same-price-at-every-dose billing once ongoing rates apply.
4. Care model and support
MedVi highlights a simple online process requiring no clinic visits plus 24/7 support from certified medical professionals. Enhance MD presents clinician-directed care and notes it has treated 10,000+ patients, with metabolic lab testing every 6 months mentioned in landing page details. Both operate via telehealth clinician review and direct-pay models.
5. Regulatory and product notes
Both providers state their compounded medications are not FDA-approved finished products and are not reviewed by FDA for safety, effectiveness, or quality. MedVi includes additional regulatory qualifiers about clinician discretion and pharmacy partnerships; Enhance MD reiterates the compounded status and clinician medical appropriateness.
Comparison table: 6 key criteria
| Criteria | MedVi | Enhance MD |
|---|---|---|
| First-month semaglutide price | $179 promotional first month, includes fast, free shipping | $49 starting first month for semaglutide |
| Tirzepatide availability | Not offered; semaglutide only | Offered; tirzepatide starting at $99 first month |
| Ongoing pricing model | Standalone month $299; three-month plan $649 available | Flat-rate pricing: same price at every dose, no escalation during titration |
| Care and support | Simple online intake, no clinic visits, 24/7 certified medical support | Clinician-directed program, 10,000+ patients treated, metabolic lab testing every 6 months |
| Medication type | Compounded semaglutide (clinically dosed) | Compounded semaglutide and tirzepatide |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
How to choose between MedVi and Enhance MD
Use the three most distinctive differences above to guide a decision: entry price, compound availability, and pricing predictability during titration. MedVi emphasizes a guided, no-clinic workflow and 24/7 certified support with a $179 promotional semaglutide month but higher ongoing standalone rates. Enhance MD emphasizes the lowest first-month semaglutide price and a flat-rate pricing model plus access to tirzepatide from $99 first month.
Check MedVi program details and support
Compare Enhance MD compounds and pricing
Choose MedVi if…
You want a semaglutide-only, clinically dosed compounded program with a simple online intake, no clinic visits, 24/7 certified medical support, and an advertised $179 promotional first month. Be aware the ongoing standalone monthly rate is higher after the promotion.
Choose Enhance MD if…
You prioritize the lowest first-month price and access to both semaglutide and tirzepatide on one platform, and you value flat-rate pricing that stays the same at every dose to avoid escalation during titration. Enhance MD lists semaglutide from $49 and tirzepatide from $99 for the first month.
All comparisons above use only the supplied facts. If additional details such as long term pricing guarantees, exact ongoing rates for every dose, or individualized medical suitability are required, those were not supplied and should be confirmed directly with each provider.
Summary
MedVi vs Enhance MD comes down to tradeoffs: MedVi offers a straightforward, fully remote semaglutide program with 24/7 support and a $179 promo first month but higher ongoing costs; Enhance MD offers the lowest-first-month semaglutide price, tirzepatide availability, and flat-rate pricing across doses. Use your priority between entry cost, compound choice, and predictable ongoing pricing to choose.